Caxton Associates »

Eagle Pharmaceuticals shares owned by Caxton Associates

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Caxton Associates

Quarter filed Position value Share count Share price at filing
2023-06-30 $389k 20k 19.44
2023-03-31 $528k 19k 28.37
2020-03-31 $210k 4.6k 45.94

More positions owned by Caxton Associates

Tesla Motors (TSLA)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Adobe Systems Incorporated (ADBE)
Cadence Design Systems (CDNS)
Centene Corporation (CNC)
Boston Scientific Corporation (BSX)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Intuitive Surgical Com New (ISRG)
Zillow Group Cl C Cap Stk (Z)
Albertsons Cos Common Stock (ACI)
Ansys (ANSS)
Teck Resources CL B (TECK)

View all positions for Caxton Associates

Top funds holding Eagle Pharmaceuticals

Stanley-Laman
Archer Investment Corp

View all funds holding Eagle Pharmaceuticals